Cell Source, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Q&A With Cell Source CEO, Itamar Shimrat – Transition From Preclinical To Human Clinical Trials
Article By: BioMedReports
Wednesday, November 5, 2014 9:59 AM EST
Recent breakthroughs from Cell Source in Veto Cell technology, which selectively tunes immune response, may change how immunologists treat blood cancers and bone marrow transplants
In this article: CLCS
Read

Latest Tweets for $CLCS

No tweets yet!